[go: up one dir, main page]

AU2020900129A0 - Oral peptide administration - Google Patents

Oral peptide administration

Info

Publication number
AU2020900129A0
AU2020900129A0 AU2020900129A AU2020900129A AU2020900129A0 AU 2020900129 A0 AU2020900129 A0 AU 2020900129A0 AU 2020900129 A AU2020900129 A AU 2020900129A AU 2020900129 A AU2020900129 A AU 2020900129A AU 2020900129 A0 AU2020900129 A0 AU 2020900129A0
Authority
AU
Australia
Prior art keywords
peptide administration
oral peptide
oral
administration
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900129A
Inventor
Victoria Cogger
Nicholas Hunt
David LeCouteur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Sydney Local Health District
Original Assignee
University of Sydney
Sydney Local Health District
Filing date
Publication date
Application filed by University of Sydney, Sydney Local Health District filed Critical University of Sydney
Publication of AU2020900129A0 publication Critical patent/AU2020900129A0/en
Priority to AU2021208711A priority Critical patent/AU2021208711A1/en
Priority to IL294799A priority patent/IL294799A/en
Priority to BR112022014119A priority patent/BR112022014119A2/en
Priority to EP21740981.2A priority patent/EP4090356A4/en
Priority to JP2022569284A priority patent/JP7752343B2/en
Priority to CN202180021243.1A priority patent/CN115443146A/en
Priority to PCT/AU2021/050027 priority patent/WO2021142516A1/en
Priority to KR1020227028361A priority patent/KR20230039594A/en
Priority to MX2022008748A priority patent/MX2022008748A/en
Priority to US17/758,961 priority patent/US20230079732A1/en
Priority to CA3168148A priority patent/CA3168148A1/en
Abandoned legal-status Critical Current

Links

AU2020900129A 2020-01-17 2020-01-17 Oral peptide administration Abandoned AU2020900129A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA3168148A CA3168148A1 (en) 2020-01-17 2021-01-18 Oral peptide administration
JP2022569284A JP7752343B2 (en) 2020-01-17 2021-01-18 Oral peptide administration
IL294799A IL294799A (en) 2020-01-17 2021-01-18 Oral peptide administration
BR112022014119A BR112022014119A2 (en) 2020-01-17 2021-01-18 ORAL ADMINISTRATION OF PEPTIDES
EP21740981.2A EP4090356A4 (en) 2020-01-17 2021-01-18 Oral peptide administration
AU2021208711A AU2021208711A1 (en) 2020-01-17 2021-01-18 Oral peptide administration
CN202180021243.1A CN115443146A (en) 2020-01-17 2021-01-18 Oral peptide administration
PCT/AU2021/050027 WO2021142516A1 (en) 2020-01-17 2021-01-18 Oral peptide administration
KR1020227028361A KR20230039594A (en) 2020-01-17 2021-01-18 oral peptide administration
MX2022008748A MX2022008748A (en) 2020-01-17 2021-01-18 ORAL ADMINISTRATION OF PEPTIDES.
US17/758,961 US20230079732A1 (en) 2020-01-17 2021-01-18 Opal peptide administration

Publications (1)

Publication Number Publication Date
AU2020900129A0 true AU2020900129A0 (en) 2020-01-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP3888591A4 (en) Oral irrigator
EP4015001A4 (en) Oral pharmaceutical composition
EP4090356A4 (en) Oral peptide administration
EP4274557A4 (en) Oral administration of ketamine
EP4190310A4 (en) Stable pharmaceutical preparation
EP4140501A4 (en) Improved peptide vaccine
AU2020900129A0 (en) Oral peptide administration
EP4065598A4 (en) Biotin moiety-conjugated polypeptide and pharmaceutical composition for oral administration comprising the same
EP4205765A4 (en) Stable pharmaceutical preparation
EP4223878A4 (en) Sars-cov-2-binding peptide
EP4061340A4 (en) Oral solid pharmaceutical compositions comprising lanthanum carbonate octahydrate
EP4251134A4 (en) Oral therapeutic delivery
AU2021900348A0 (en) Oral therapeutic delivery
HK40094042A (en) Therapeutic peptide formulations
AU2020904426A0 (en) Oral therapeutic delivery
HK40103690A (en) Novel combined administration
HK40110422A (en) Peptide drug conjugates
HK40109987A (en) Oral dosage forms
HK40081384A (en) Oral solid preparations
HK40100860A (en) Pharmaceutical formulations
HK40119006A (en) Administration device
CA3289959A1 (en) Oral pharmaceutical compositions
HK40091202A (en) Pharmaceutical formulations
HK40109710A (en) Oral formulation
HK40089663A (en) Pharmaceutical formulations